口服和非口服偏头痛预防性治疗对有睡眠问题的偏头痛患者自我报告的主观睡眠质量的疗效:回顾与荟萃分析。

IF 3.4 3区 医学 Q2 CLINICAL NEUROLOGY
W. P. J. van Oosterhout, L. Kanis, N. J. Wiendels, J. W. Reijngoudt
{"title":"口服和非口服偏头痛预防性治疗对有睡眠问题的偏头痛患者自我报告的主观睡眠质量的疗效:回顾与荟萃分析。","authors":"W. P. J. van Oosterhout,&nbsp;L. Kanis,&nbsp;N. J. Wiendels,&nbsp;J. W. Reijngoudt","doi":"10.1111/jsr.14241","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>This study aims to investigate the effects of oral and non-oral migraine prophylaxis on subjective sleep quality in migraine patients with sleep problems. A bidirectional relationship between migraine and sleep is presumed, although this relationship is not fully clarified. Possibly, prophylactic treatment of migraine aiming at a reduction of migraine attack frequency can also positively affect the quality of sleep for patients with migraine with sleep problems. PubMed, Cochrane, Embase and CINAHL databases were searched in March 2022 for studies evaluating prophylactic treatment of migraine and the impact on perceived sleep quality (Pittsburgh Sleep Quality Index or Insomnia Severity Index). A systematic review using the McMaster Tool and a random-effects meta-analysis (effect size Cohen's <i>d</i>) were conducted. Seven studies were identified, including 989 participants, of which 844/989 (85.3%) female, with a mean (SD) age of 41.3 (12.1) years. In 6/7 (85.7%) studies, monthly migraine days improved (<i>p</i> &lt; 0.002). Five out of six (83.3%) studies presented a relevant improvement in quality of sleep (<i>p</i> &lt; 0.05), and one study reported a clinically meaningful improvement in the treatment group (Insomnia Severity Index change &gt;7, in &gt;50% of participants). The meta-analysis showed a large effect size of 1.09 (95% confidence interval 0.57–1.62; overall <i>p</i> &lt; 0.001; Cochran's <i>Q</i> &lt; 0.0001) for migraine prophylaxis on improving sleep quality. In conclusion, prophylactic migraine treatment improves sleep quality in patients with migraine and sleep problems, as measured with self-reported questionnaires Pittsburgh Sleep Quality Index and Insomnia Severity Index. Unfortunately, some included studies used prophylactic treatment that is not in current (international) guidelines. The evidence for this improvement in quality of sleep is strong, and seems a generic effect of migraine prophylaxis.</p>\n </div>","PeriodicalId":17057,"journal":{"name":"Journal of Sleep Research","volume":"34 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of oral and non-oral migraine prophylactic treatment on self-reported subjective sleep quality in migraine patients with sleep problems: A review and meta-analysis\",\"authors\":\"W. P. J. van Oosterhout,&nbsp;L. Kanis,&nbsp;N. J. Wiendels,&nbsp;J. W. Reijngoudt\",\"doi\":\"10.1111/jsr.14241\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>This study aims to investigate the effects of oral and non-oral migraine prophylaxis on subjective sleep quality in migraine patients with sleep problems. A bidirectional relationship between migraine and sleep is presumed, although this relationship is not fully clarified. Possibly, prophylactic treatment of migraine aiming at a reduction of migraine attack frequency can also positively affect the quality of sleep for patients with migraine with sleep problems. PubMed, Cochrane, Embase and CINAHL databases were searched in March 2022 for studies evaluating prophylactic treatment of migraine and the impact on perceived sleep quality (Pittsburgh Sleep Quality Index or Insomnia Severity Index). A systematic review using the McMaster Tool and a random-effects meta-analysis (effect size Cohen's <i>d</i>) were conducted. Seven studies were identified, including 989 participants, of which 844/989 (85.3%) female, with a mean (SD) age of 41.3 (12.1) years. In 6/7 (85.7%) studies, monthly migraine days improved (<i>p</i> &lt; 0.002). Five out of six (83.3%) studies presented a relevant improvement in quality of sleep (<i>p</i> &lt; 0.05), and one study reported a clinically meaningful improvement in the treatment group (Insomnia Severity Index change &gt;7, in &gt;50% of participants). The meta-analysis showed a large effect size of 1.09 (95% confidence interval 0.57–1.62; overall <i>p</i> &lt; 0.001; Cochran's <i>Q</i> &lt; 0.0001) for migraine prophylaxis on improving sleep quality. In conclusion, prophylactic migraine treatment improves sleep quality in patients with migraine and sleep problems, as measured with self-reported questionnaires Pittsburgh Sleep Quality Index and Insomnia Severity Index. Unfortunately, some included studies used prophylactic treatment that is not in current (international) guidelines. The evidence for this improvement in quality of sleep is strong, and seems a generic effect of migraine prophylaxis.</p>\\n </div>\",\"PeriodicalId\":17057,\"journal\":{\"name\":\"Journal of Sleep Research\",\"volume\":\"34 1\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Sleep Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jsr.14241\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sleep Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jsr.14241","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在调查口服和非口服偏头痛预防药物对有睡眠问题的偏头痛患者主观睡眠质量的影响。偏头痛与睡眠之间存在双向关系,但这种关系尚未完全明确。以减少偏头痛发作频率为目的的偏头痛预防性治疗可能也会对有睡眠问题的偏头痛患者的睡眠质量产生积极影响。2022年3月,我们在PubMed、Cochrane、Embase和CINAHL数据库中检索了有关偏头痛预防性治疗及其对睡眠质量(匹兹堡睡眠质量指数或失眠严重程度指数)影响的评估研究。研究人员使用麦克马斯特工具进行了系统综述,并进行了随机效应荟萃分析(效应大小为 Cohen's d)。共发现了七项研究,包括 989 名参与者,其中 844/989 人(85.3%)为女性,平均(标清)年龄为 41.3(12.1)岁。在6/7(85.7%)项研究中,每月偏头痛天数有所改善(P 7,大于50%的参与者)。荟萃分析表明,该疗法的效应大小为 1.09(95% 置信区间为 0.57-1.62;总 p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy of oral and non-oral migraine prophylactic treatment on self-reported subjective sleep quality in migraine patients with sleep problems: A review and meta-analysis

This study aims to investigate the effects of oral and non-oral migraine prophylaxis on subjective sleep quality in migraine patients with sleep problems. A bidirectional relationship between migraine and sleep is presumed, although this relationship is not fully clarified. Possibly, prophylactic treatment of migraine aiming at a reduction of migraine attack frequency can also positively affect the quality of sleep for patients with migraine with sleep problems. PubMed, Cochrane, Embase and CINAHL databases were searched in March 2022 for studies evaluating prophylactic treatment of migraine and the impact on perceived sleep quality (Pittsburgh Sleep Quality Index or Insomnia Severity Index). A systematic review using the McMaster Tool and a random-effects meta-analysis (effect size Cohen's d) were conducted. Seven studies were identified, including 989 participants, of which 844/989 (85.3%) female, with a mean (SD) age of 41.3 (12.1) years. In 6/7 (85.7%) studies, monthly migraine days improved (p < 0.002). Five out of six (83.3%) studies presented a relevant improvement in quality of sleep (p < 0.05), and one study reported a clinically meaningful improvement in the treatment group (Insomnia Severity Index change >7, in >50% of participants). The meta-analysis showed a large effect size of 1.09 (95% confidence interval 0.57–1.62; overall p < 0.001; Cochran's Q < 0.0001) for migraine prophylaxis on improving sleep quality. In conclusion, prophylactic migraine treatment improves sleep quality in patients with migraine and sleep problems, as measured with self-reported questionnaires Pittsburgh Sleep Quality Index and Insomnia Severity Index. Unfortunately, some included studies used prophylactic treatment that is not in current (international) guidelines. The evidence for this improvement in quality of sleep is strong, and seems a generic effect of migraine prophylaxis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Sleep Research
Journal of Sleep Research 医学-临床神经学
CiteScore
9.00
自引率
6.80%
发文量
234
审稿时长
6-12 weeks
期刊介绍: The Journal of Sleep Research is dedicated to basic and clinical sleep research. The Journal publishes original research papers and invited reviews in all areas of sleep research (including biological rhythms). The Journal aims to promote the exchange of ideas between basic and clinical sleep researchers coming from a wide range of backgrounds and disciplines. The Journal will achieve this by publishing papers which use multidisciplinary and novel approaches to answer important questions about sleep, as well as its disorders and the treatment thereof.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信